Hansa Biopharma

Virtual Investor Event

Autoimmune Deep Dive
Guillain-Barré Syndrome

Join Hansa Biopharma for an investor event featuring two KOLs discussing unmet need and current treatment landscape for Guillain-Barré syndrome (GBS).

June 16, 14:00 CEST/8:00 AM ET

Register and attend
CareersPipelineCollaboration RareInnovation SVGOMG The best SVG optimizer and minifier Open SVG Paste markup Demo Contribute SVGOMG provides you several options to clean and compress your SVG files. Clean up, remove, merge, minify. Upload or copy the source of your SVG to get started! 947 bytes → 267 bytes 28.19% Finance peopleAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes
Researcher examining bacteria

Media

Media

Our latest announcements

Read all press releases

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

09/06/2025
Hansa Biopharma plans restructuring to optimize resource allocation and improve operational efficiency

Regulatory press release

26/05/2025
Notice to Annual General Meeting in Hansa Biopharma AB (publ)

Regulatory press release

26/05/2025
Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS

14/05/2025

Media articles

Insights

Read all insights

Collaboration across the continuum of care to improve equity for highly sensitized people in kidney transplantation
17/07/2024
A concerted collaboration to advance treatment options for people living with rare diseases
26/06/2024
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024
Addressing barriers to gene therapy treatment
31/01/2024

Patients' perspective

Life on tour with chronic kidney disease

“I had always played the guitar and wrote songs but never really did anything with it. Nothing was going to hold me back now! No more excuses… there wasn’t time!”
Employee stories

Working in an epicentre of pioneering innovation

“The key to our collective success at Hansa Biopharma goes far beyond our scientific breakthroughs, as it stems from the amazing team spirit we have built.”
Patients' perspective

Taking care of a transplanted kidney through physical and mental health

“And people say to me: I never would have guessed that you had a kidney transplant… when I hear those words, they keep me motivated, and keep me going.”
Patients' perspective

Suspended time: a journey from diagnosis to transplant

"Dialysis may sound simple, but it isn’t, and over the course of his treatment Ron underwent several different kinds, all of which made him feel awful."
Read all stories
Global Corporate Affairs

Stephanie Kenney

Vice President Global Corporate Affairs

Email: [email protected]

E-MAIL

Sign up to receive updates on the latest company news and filings

Choose type

I consent to Hansa Biopharma handling my personal data. See our Privacy Policy for information about how we handle personal data.

Thank you. You will get an e-mail message to activate your subscription.